These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 478636)

  • 1. Rabies virus immunity in genetically selected high- and low-responder lines of mice.
    Nilsson MR; Sant'anna OA; Siqueira M; Nilsson TT; Gennari M
    Infect Immun; 1979 Jul; 25(1):23-6. PubMed ID: 478636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic control of antibody production and correlation with vaccine induced resistance to rabies virus in high and low antibody responder mice.
    De Franco M; Massa S; Vassão RC; Siqueira M; Sant'Anna OA
    Arch Virol; 1996; 141(8):1397-406. PubMed ID: 8856022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of different specific immunological parameters after rabies vaccination in mice.
    Blancou J; Andral L; Lagrange PH; Tsiang H
    Infect Immun; 1979 Jun; 24(3):600-5. PubMed ID: 468369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell mediated immune response in canine antirabies vaccination.
    Timenetsky J; Chamelet EL; Mendes NF; Pereira OA
    Rev Inst Med Trop Sao Paulo; 1985; 27(1):1-5. PubMed ID: 4035202
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice.
    Lafon M; Bourhy H; Sureau P
    Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice.
    Templeton JW; Holmberg C; Garber T; Sharp RM
    J Virol; 1986 Jul; 59(1):98-102. PubMed ID: 3086569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
    Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF
    Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabies antibody titres in vaccinated reindeer.
    Sihvonen L; Kulonen K; Soveri T; Nieminen M
    Acta Vet Scand; 1993; 34(2):199-202. PubMed ID: 8266898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG modulation of delayed type hypersensitivity, humoral response and acquired resistance after rabies vaccination.
    Tsiang H; Blancou J; Lagrange PH
    Arch Virol; 1981; 69(3-4):167-76. PubMed ID: 7295038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complement-fixing rabies antibodies in mice vaccinated and posteriorly challenged].
    Oliveira LH; Andrade CM; Reis W
    An Microbiol (Rio J); 1980; 25():135-47. PubMed ID: 6982627
    [No Abstract]   [Full Text] [Related]  

  • 13. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody.
    Lodmell DL; Parnell MJ; Weyhrich JT; Ewalt LC
    Vaccine; 2003 Sep; 21(25-26):3998-4002. PubMed ID: 12922136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of systemic injection of rabies immunoglobulin in rabies vaccination.
    Wu W; Liu S; Yu P; Tao X; Lu X; Yan J; Wang Q; Zhang Z; Zhu W
    Arch Virol; 2017 Jun; 162(6):1701-1703. PubMed ID: 28188373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.
    Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H
    J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers.
    Lodmell DL; Parnell MJ; Bailey JR; Ewalt LC; Hanlon CA
    Vaccine; 2002 May; 20(17-18):2221-8. PubMed ID: 12009276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model in mice for the study of the early death phenomenon after vaccination and challenge with rabies virus.
    Blancou J; Andral B; Andral L
    J Gen Virol; 1980 Oct; 50(2):433-5. PubMed ID: 7463005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on Japanese-produced chick embryo cell culture rabies vaccines.
    Arai YT; Ogata T; Oya A
    Am J Trop Med Hyg; 1991 Feb; 44(2):131-4. PubMed ID: 2012255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies.
    Welch RJ; Anderson BL; Litwin CM
    J Med Microbiol; 2009 Jun; 58(Pt 6):806-810. PubMed ID: 19429758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination.
    Li Y; Zhou M; Luo Z; Zhang Y; Cui M; Chen H; Fu ZF; Zhao L
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.